Colitis: all 1,059 studies
Page 9 of 11. Open to participants first (124), then studies with results posted, then the rest; newest registration first within each.
- Responsiveness of Endoscopic Evaluation in UCCompletedNCT01960439
- A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT01959282Phase 2
- Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in ChildrenCompletedNCT01947101Phase 1
- Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative ColitisCompletedNCT01941589Phase 4
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Pathogenic Mechanisms in C Diff Infection and ColitisCompletedNCT01930032
- Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC PatientsCompletedNCT01929668Not applicable
- Case-Control Study to Identify Risk Factors for Microscopic ColitisCompletedNCT01928667
- The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease PatientsCompletedNCT01916161
- Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative ColitisStatus unknownNCT01914887Phase 1/2
- A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative ColitisCompletedNCT01900574Phase 1
- Faecal Microbiota Transplantation in Ulcerative ColitisCompletedNCT01896635Phase 2
- Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's DiseaseCompletedNCT01891214
- Care Path for the Management of Ulcerative ColitisTerminatedNCT01882426Phase 4
- Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)TerminatedNCT01861249Phase 2
- Assessment of Disease Activity in Ulcerative Colitis by Endoscopic UltrasoundCompletedNCT01852760
- A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)Active, not recruitingNCT01848561
- Ulcerative Colitis and Vitamin D SupplementationWithdrawnNCT01846026Phase 1/2
- A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative ColitisCompletedNCT01839214Phase 2
- Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative ProctitisCompletedNCT01837615Phase 2
- Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative ColitisCompletedNCT01829321Phase 2
- Infants With Protein Sensitive ColitisCompletedNCT01813526Not applicable
- Low Dose Naltrexone in Symptomatic Inflammatory Bowel DiseaseWithdrawnNCT01810185Phase 2
- Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing CholangitisCompletedNCT01798953
- Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody LevelsWithdrawnNCT01787786
- Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)CompletedNCT01787253
- Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative ColitisStatus unknownNCT01783119Early Phase 1
- Eosinophilic Gastrointestinal Disorders Patient RegistryWithdrawnNCT01779154
- Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli NissleCompletedNCT01772615Phase 4
- Effect of FAn-7 in UC ActivityStatus unknownNCT01771224Early Phase 1
- Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk FactorsCompletedNCT01764542Not applicable
- Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative ColitisCompletedNCT01759056Phase 1
- Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transitStatus unknownNCT01752361
- Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transitStatus unknownNCT01745029
- Fecal Microbiota Transplantation for Ulcerative ColitisTerminatedNCT01742754Not applicable
- Evaluation Of The Pillcam™ Colon Capsule Endoscopy (Pcce-2) In Pediatric Ulcerative ColitisCompletedNCT01740349
- A Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among AdultsTerminatedNCT01733966Phase 3
- Multimodal Approach in IBD PatientsStatus unknownNCT01705522
- Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of TreatmentCompletedNCT01684514Not applicable
- Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)CompletedNCT01678300
- Adalimumab in the Treatment of Chronic PouchitisCompletedNCT01670240Phase 3
- Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative ColitisTerminatedNCT01659138Phase 2
- A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative ColitisWithdrawnNCT01658605Phase 2
- Observational Study in the Management of Ulcerative Colitis With Oral 5-ASACompletedNCT01654783
- Transplantation of Faeces in Ulcerative Colitis; Restoring Nature's HomeostasisCompletedNCT01650038Phase 2
- Vitamin D Treatment in Ulcerative ColitisWithdrawnNCT01640496Not applicable
- Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes SevereStatus unknownNCT01630096Phase 4
- Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative ColitisCompletedNCT01612039Phase 2
- Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis PatientsCompletedNCT01604564
- Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic ColitisCompletedNCT01561248Not applicable
- A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative ColitisCompletedNCT01551290Phase 3
- Phase I Trial of a Single Dose of CRS3123CompletedNCT01551004Phase 1
- Fecal Biotherapy for the Induction of Remission in Active Ulcerative ColitisCompletedNCT01545908Phase 2
- Improving Medication Adherence in Pediatric Inflammatory Bowel DiseaseCompletedNCT01536509Not applicable
- Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)CompletedNCT01534312Not applicable
- Mesalazine (PENTASA®) in Ulcerative ColitisCompletedNCT01517607
- Tolerability of Pentasa Sachet in Patients With Ulcerative ColitisCompletedNCT01517594
- Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel DiseaseStatus unknownNCT01505842Not applicable
- Usefulness of Chromoendoscopy in Diagnosing Microscopic ColitisStatus unknownNCT01504048Not applicable
- Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative ColitisStatus unknownNCT01494857Phase 3
- Mind-Body Medicine and Ulcerative ColitisCompletedNCT01491997Not applicable
- Adacolumn in Refractory UC Patients TrialCompletedNCT01481142Phase 4
- Role of Healthy Bacteria in Ulcerative ColitisStatus unknownNCT01479660Phase 4
- Disease Course in an IBD Cohort in the Era of Biological TreatmentCompletedNCT01468090
- PillCam Colon Capsule Endoscopy for Ulcerative ColitisCompletedNCT01467609
- Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT01461317Phase 2
- A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative ColitisCompletedNCT01453491Phase 1
- Optimal Surgical Treatment Of Fulminant Clostridium Difficile ColitisTerminatedNCT01441271Not applicable
- Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative ColitisWithdrawnNCT01434576Phase 1
- Rectal Tacrolimus in the Treatment of Resistant Ulcerative ProctitisCompletedNCT01418131Phase 4
- Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative ColitisCompletedNCT01408810Phase 4
- Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative ColitisCompletedNCT01387698
- Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis PatientsTerminatedNCT01375179Phase 2
- User Surveillance in Ulcerative ColitisCompletedNCT01363453
- Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)CompletedNCT01346826Phase 4
- Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) PatientsCompletedNCT01341808Phase 4
- Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT01336465Phase 2
- A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen PanelCompletedNCT01326013
- Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative ColitisCompletedNCT01320436Phase 3
- A Study of a Single Dose of ASP3291 in Subjects With Ulcerative ColitisCompletedNCT01320332Phase 1
- Small Bowel Transit Time in Clostridium Difficile ColitisTerminatedNCT01309750
- Nutritional State and Intake Nutrients Assessment in Ulcerative ColitisCompletedNCT01301976
- Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative ColitisCompletedNCT01294410Phase 2
- Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)WithdrawnNCT01293656
- Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.CompletedNCT01290042Phase 1
- Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative ColitisCompletedNCT01282905
- SOIBD Collagenous Colitis Maintenance StudyCompletedNCT01278082Phase 3
- Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission PhaseCompletedNCT01257399Phase 3
- Comparative Efficacy and Safety Study in Patients With Active Ulcerative ColitisCompletedNCT01257386Phase 3
- Profermin® in Active Ulcerative ColitisCompletedNCT01245465Phase 1/2
- Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative ColitisStatus unknownNCT01221428Phase 1/2
- Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative ColitisStatus unknownNCT01216280Phase 2
- Budesonide Versus Mesalazine Versus Placebo in Lymphocytic ColitisCompletedNCT01209208Phase 3
- Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative ColitisCompletedNCT01201122Phase 4
- Trial on Profermin and Fresubin in Ulcerative ColitisCompletedNCT01193894Phase 2/3
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative ColitisTerminatedNCT01164904Phase 1
- Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative ColitisCompletedNCT01149707Phase 2
- A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy VolunteersCompletedNCT01149694Phase 1
- Clinical Outcome After Close Rectal Ileo Pouch Anal Anastomosis for Colitis Ulcerosa(CU)Status unknownNCT01111708Not applicable
- A Study of Pentasa in Patients With Ulcerative ColitisCompletedNCT01104753